J
James Brian Byrd
Researcher at University of Michigan
Publications - 83
Citations - 3195
James Brian Byrd is an academic researcher from University of Michigan. The author has contributed to research in topics: Angioedema & Angiotensin-converting enzyme. The author has an hindex of 20, co-authored 79 publications receiving 2108 citations. Previous affiliations of James Brian Byrd include Vanderbilt University Medical Center & University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
Jan Van Deun,Pieter Mestdagh,Patrizia Agostinis,Özden Akay,Sushma Anand,Jasper Anckaert,Zoraida Andreu Martinez,Tine Baetens,Els Beghein,Laurence Bertier,Geert Berx,Janneke Boere,Stephanie Boukouris,Michel Bremer,Dominik Buschmann,James Brian Byrd,Clara Casert,Lesley Cheng,Anna Cmoch,Delphine Daveloose,Eva De Smedt,Seyma Demirsoy,Victoria Depoorter,Bert Dhondt,Tom A. P. Driedonks,Aleksandra M. Dudek,Abdou ElSharawy,Ilaria Floris,Andrew D Foers,Kathrin Gärtner,Abhishek D. Garg,Edward Geeurickx,Jan Gettemans,Farzaneh Ghazavi,Bernd Giebel,Tom Groot Kormelink,Grace V. Hancock,Hetty Helsmoortel,Andrew F. Hill,Vincent Hyenne,Hina Kalra,David Kim,Joanna Kowal,Joanna Kowal,Sandra Kraemer,Petra Leidinger,Carina Leonelli,Yaxuan Liang,Lien Lippens,Shu Liu,Alessandra Lo Cicero,Alessandra Lo Cicero,Shaun Martin,Suresh Mathivanan,Prabhu Mathiyalagan,Tamás Matusek,Gloria Milani,Marta Monguió-Tortajada,Liselot Mus,Dillon C. Muth,Andrea Németh,Esther N. M. Nolte-‘t Hoen,Lorraine O'Driscoll,Roberta Palmulli,Roberta Palmulli,Michael W. Pfaffl,Bjarke Primdal-Bengtson,Bjarke Primdal-Bengtson,Erminia Romano,Quentin Rousseau,Susmita Sahoo,Natalia G. Sampaio,Monisha Samuel,Benjamin J. Scicluna,Bieke Soen,Anneleen Steels,Johannes V. Swinnen,Maarit Takatalo,Safia Thaminy,Clotilde Théry,Clotilde Théry,Joeri Tulkens,Isabel Van Audenhove,Susanne G. van der Grein,Alan Van Goethem,Martijn J. C. van Herwijnen,Guillaume van Niel,Guillaume van Niel,Nadine Van Roy,Alexander R. van Vliet,Niels Vandamme,Suzanne Vanhauwaert,Glenn Vergauwen,Frederik J. Verweij,Frederik J. Verweij,Annelynn Wallaert,Marca H. M. Wauben,Kenneth W. Witwer,Marijke I. Zonneveld,Olivier De Wever,Jo Vandesompele,An Hendrix +101 more
TL;DR: It is argued that the field of extracellular vesicle (EV) biology needs more transparent reporting to facilitate interpretation and replication of experiments and EV-TRACK, a crowdsourcing knowledgebase that centralizes EV biology and methodology, is described.
Journal ArticleDOI
Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing.
Brett K. Beaulieu-Jones,Zhiwei Steven Wu,Christopher J. Williams,Ran Lee,Sanjeev P. Bhavnani,James Brian Byrd,Casey S. Greene +6 more
TL;DR: This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals.
Journal ArticleDOI
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
Jordana B. Cohen,Thomas C. Hanff,Thomas C. Hanff,Preethi William,Nancy K. Sweitzer,Nelson R. Rosado-Santander,Carola Medina,Juan E. Rodriguez-Mori,Nicolas Federico Renna,Tara I. Chang,Vicente F. Corrales-Medina,Jaime Andrade-Villanueva,Alejandro Barbagelata,Roberto Cristodulo-Cortez,Omar A Díaz-Cucho,Jonas Spaak,Carlos Alfonso,Renzo P. Valdivia-Vega,Mirko Villavicencio-Carranza,Ricardo J Ayala-García,Carlos Augusto Castro-Callirgos,Luz A. González-Hernández,Eduardo F Bernales-Salas,Johanna C. Coacalla-Guerra,Cynthia D Salinas-Herrera,Liliana Nicolosi,Mauro Basconcel,James Brian Byrd,Tiffany Sharkoski,Luis E Bendezú-Huasasquiche,Jesse Chittams,Daniel L. Edmonston,Charles R. Vasquez,Charles R. Vasquez,Julio A. Chirinos +34 more
TL;DR: The REPLACE COVID trial as mentioned in this paper evaluated whether continuing versus discontinuing renin-angiotensin system inhibitors (ANGI-converting enzyme inhibitors or angiotENSin receptor blockers) affects outcomes in patients admitted to hospital with COVID-19.
Journal ArticleDOI
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema
TL;DR: The remitting and relapsing nature of ACE inhibitor-associated angioedema can confound clinical recognition of the adverse event but also provides clues to its causes.
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor-associated angioedema
James Brian Byrd,Stephanie Harris,James V. Gainer,Chang Yu,Ajai Shreevatsa,Pradeep Putlur,John H. Nadeau,Karine Touzin,Marshall L. Summar,Albert Adam,Nancy J. Brown +10 more
TL;DR: This case-control study tested the hypothesis that dipeptidyl peptidase IV activity and antigen are decreased in sera of patients with a history of angiotensin-converting enzyme inhibitor–associated angioedema, and found that it was true.